| Variables |
Group I |
Group II |
p-value |
| Age |
53.0 ± 15.9 |
59.8 ± 7.9 |
0.275 |
| Gender |
|
|
0.153 |
| Male |
6 (66.7%) |
2 (22.2%) |
|
| Female |
3 (33.3%) |
7 (77.8%) |
|
| Disease duration |
24 (6-96) |
60 (5-120) |
0.297 |
| Concomitant disease |
5 (55.6%) |
6 (66.7%) |
1.000 |
| Drug therapy |
2 (22.2%) |
1 (11.1%) |
1.000 |
|
